Identifier |
Residue |
Sequence |
Organism |
Cell Line |
SIGNOR-259902 |
|
|
Homo sapiens |
|
pmid |
sentence |
20350663 |
Rituximab is a class I chimeric anti-CD20 antibody that has shown efficacy in chronic lymphocytic leukemia (CLL), both as a single agent and in combination with traditional chemotherapies. |
|